Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Protagenic Therapeutics (PTIX) has issued an announcement.
In a positive turn for investors, a company has successfully addressed its previous Nasdaq non-compliance issue by maintaining its stock price above the $1.00 minimum bid price for ten consecutive trading days. This accomplishment has resulted in the Nasdaq Listing Qualifications Department closing the deficiency notice, ensuring the company’s continued listing on the exchange and potentially restoring investor confidence in its financial stability.
For detailed information about PTIX stock, go to TipRanks’ Stock Analysis page.
